FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $367,000 | -38.4% | 110,343 | -43.7% | 0.01% | -30.8% |
Q3 2019 | $596,000 | +70.8% | 196,160 | +33.7% | 0.01% | +44.4% |
Q2 2019 | $349,000 | -20.7% | 146,745 | +25.0% | 0.01% | -30.8% |
Q1 2019 | $440,000 | +29.8% | 117,367 | +24.4% | 0.01% | -7.1% |
Q4 2018 | $339,000 | -40.7% | 94,378 | -5.5% | 0.01% | -17.6% |
Q3 2018 | $572,000 | +7.5% | 99,901 | -6.0% | 0.02% | -10.5% |
Q2 2018 | $532,000 | +14.9% | 106,243 | +17.7% | 0.02% | -17.4% |
Q1 2018 | $463,000 | +97.0% | 90,263 | +130.5% | 0.02% | +21.1% |
Q4 2017 | $235,000 | – | 39,160 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|